Bruchfeld, A
573  Ergebnisse:
Personensuche X
?
 
?
4

Pentraxin-3 – a potential biomarker in ANCA-associated vasc..:

Jonasdottir, AD ; Antovic, A ; Qureshi, AR...
Scandinavian Journal of Rheumatology.  52 (2022)  3 - p. 293-301 , 2022
 
?
5

POS-444 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBI..:

Jayne, D. ; Merkel, P.A. ; Bekker, P....
Kidney International Reports.  7 (2022)  2 - p. S197 , 2022
 
?
 
?
7

Risks and treatment related aspects of COVID-19 infection i..:

Antovic, A ; Bruchfeld, A ; Ekland, J...
Scandinavian Journal of Rheumatology.  52 (2022)  4 - p. 418-423 , 2022
 
?
9

Microparticles expressing myeloperoxidase as potential biom..:

Manojlovic, M. ; Juto, A. ; Jonasdottir, A....
Journal of Molecular Medicine.  98 (2020)  9 - p. 1279-1286 , 2020
 
?
 
?
13

Meropenem-clavulanate has high in vitro activity against mu..:

Davies Forsman, L. ; Giske, C.G. ; Bruchfeld, J....
International Journal of Mycobacteriology.  4 (2015)  - p. 80-81 , 2015
 
?
14

GLOMERULONEPHRITIDES:

Jayne, D. R. W. ; Bruchfeld, A. ; Schaier, M....
Nephrology Dialysis Transplantation.  29 (2014)  suppl 3 - p. iii27-iii29 , 2014
 
?
15

Plasma S100A12 and soluble receptor of advanced glycation e..:

Isoyama, N. ; Leurs, P. ; Qureshi, A. R....
Nephrology Dialysis Transplantation.  30 (2014)  1 - p. 84-91 , 2014
 
1-15